Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 17, 2022
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
Patrick Trucchio Maintained (ALT) at Strong Buy with Increased Target to $50 on, Aug 17th, 2022
Patrick Trucchio of HC Wainwright & Co., Maintained "Altimmune, Inc." (ALT) at Strong Buy with Increased Target from $25 to $50 on, Aug 17th, 2022.
Patrick has made no other calls on ALT in the last 4 months.
There are 2 other peers that have a rating on ALT. Out of the 2 peers that are also analyzing ALT, 0 agree with Patrick's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Patrick
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $26 on, Friday, August 12th, 2022
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, May 18th, 2022
